Oral squamous cell carcinoma: Etiology, pathogenesis and prognostic value of genomic alterations

Indian Journal of Cancer

Volumn 43, Issue 2, 2006, Pages 60-66

  Mehrotra, Ravi ^a   Yadav, S ^a  

^a UNIVERSITY OF ALLAHABAD   (India)

Author keywords

Apoptosis; LCM; Oral cancer; Telomerase activity

Indexed keywords

EID: 33745598785     PISSN: 0019509X     EISSN: None     Source Type: Journal    
DOI: 10.4103/0019-509X.25886     Document Type: Review

References (54)

1. Landis SH, Murray T, Bolden S, Wingo PA, Cancer statistics, 1999. CA Cancer J Clin 1999;49:8-31.
2. Mehrotra R, Gupta A, Singh M, Ibrahim R. Application of cytology and molecular biology in diagnosing premalignant or malignant oral lesions. Mol Cancer 2006;5:11.
3. Meyskens FL. Biology and intervention of premalignant process. Can Bull 1991;43:475-80.
4. Sunny L, Yeole BB, Hakama M, Shiri R, Sastry PS, Mathews S, et al. Oral cancers in Mumbai, India: A fifteen years perspective with respect to incidence trend and cumulative risk. Asian Pac J Cancer Prev 2004;5:294-300.
5. Daftary DK, Murti PR, Bhonsle RB, et al. Risk factors and risk markers for oral cancer in high incidence areas of the world. In: Johnson NW, editor. Oral Cancer, Vol. 2. Cambridge University Press: Cambridge; 1991. p. 29-63.
6. Walker DM, Boey G, McDonald LA. The pathology of oral cancer. Pathology 2003;35:376-83.
7. Franceschi S, Bidoli P, Herrero R, Munoz N. Comparison of cancers of the oral cavity and pharynx world wide:etiological clues. Oral Oncol 2000;36:106-15.
8. Manjari M, Popli R, Paul S, Gupta VP, Kaholon SK. Prevalence of oral cavity, pharynx, larynx and nasal cavity malignancies in Amritsar, Punjab. Indian J Otolaryngol Head Neck Surg 1999;48:191-5.
9. International Agency for Research on Cancer (IARC). Tobacco smoking. IARC Monograph on the evaluation of carcinogenic risks of chemicals to humans. IARC: Lyon, France; 1986. p. 1-421.
10. Kawajiri K, Fujii-Kuriyama Y. P450 and human cancer. Jpn J Cancer Res 1991;82:1325-35.
11. Merchant A, Husain SS, Hosain M, Fikree FF, Pitiphat W, Siddiqui AR, et al. Paan without tobacco: An independent risk factor for oral cancer. Intl J Cancer 2000;86:128-31.
12. Nair J, Ohshima H, Friesen M, Croisy A, Bhide SV, Bartsch H. Tobacco-specific and betel nut-specific N-nitroso compounds: Occurrence in saliva and urine of betel quid chewers and formation in vitro by nitrosation of betel quid. Carcinogenesis 1985;6:295-303.
13. Prokopczyk B, Rivenson A, Bertinato P, Brunnemann KD, Hoffmann D. 3-(Methylnitrosamino) propionitrile: Occurrence in saliva of betel quid chewers, carcinogenicity and DNA methylation in F344 rats. Cancer Res 1987;47:467-71.
14. International Agency for Research on Cancer (IARC). Alcohol drinking. IARC Monograph on the evaluation of carcinogenic risks of chemicals to humans. IARC: Lyon, France; 1989. p. 1-416.
15. Blot WJ. Alcohol and cancer. Cancer Res 1992;52:2119s-23s.
16. Harty LC, Caporaso NE, Hayes RB, Winn DM, Bravo-Otero E, Blot WJ, et al. Alcohol dehydrogenase 3 genotype and risk of oral cavity and pharyngeal cancers. J Natl Cancer Inst 1997;89:1698-705.
17. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92:709-20.
18. McKaig RG, Baric RS, Olshan AF. Human papillomavirus and head and neck cancer: Epidemiology and molecular biology. Head Neck 1998;20:250-65.
19. DiPaolo JA, Woodworth CD, Popescu NC, Koval DL, Lopez JV, Doniger J. HSV-2 induced tumorigenicity in HPV-16-immortalised human genital keratinocytes. Virology 1990; 177:777-9.
20. Scully C. New aspects of oral viral diseases. Curr Top Pathol 1996;90:29-96.
21. Scully C. Oral squamous cell carcinoma; From a hypothesis about a virus, to concern about possible sexual transmission. Oral Oncol 2002;38:227-34.
22. McLaughlin JK, Gridley G, Block G, Winn DM, Preston-Martin S, Schoenberg JB, et al. Dietary factors in oral and pharyngeal cancer. J Natl Cancer Inst 1988;80: 1237-43.
23. De Stefani E, Deneo-Pellegrini H, Mendilaharsu M, Ronco A. Diet and risk of cancer of the upper aerodigestive tract-I. Foods. Oral Oncol 1999;35:17-21.
24. Negri E, Franceschi S, Bosetti C, Levi F, Conti E, Parpinel M, et al. Selected micronutrients and oral and pharyngeal cancer. Int J Cancer 2000;86:122-7.
25. Spitz MR, Fueger JJ, Beddingfield NA, Annegers JF, Hsu TC, Newell GR, et al. Chromosome sensitivity to bleomycin induced mutagenesis an independent risk factor for upper aerodigestive tract cancer. Cancer Res 1989;49:4626-8.
26. Villaret DB, Wang T, Dillon D, Xu J, Sivam D, Cheever MA, et al. Identification of genes over expressed in head and neck squamous cell carcinoma using a combination of complementary DNA subtraction and microarray analysis. Laryngoscope 2000; 110:374-81.
27. Scully C, Laskaris G, Pindborg J, Porter SR, Reichart P. Oral manifestations of HIV and their management. I. More common lesions. Oral Surg Oral Med Oral Pathol 1991;71:158-66.
28. Flaitz CM, Hicks MJ. Role of lymphotrotrophic herpesvirus in malignancies associated with immunosuppressed states. In: Millard HD, Mason DK, editors. Perspectives on the 1998 3rd World Workshop on Oral Medicine. University of Michigan Press: Ann Arbor, MI; 2000.
29. Harris JP, Penn I. Immunosuppression and the development of malignancies of the upper airway and related structures. Laryngoscope 1981;91:520-8.
30. Cawson RA. Leukoplakia and oral cancer. Proc R Soc Med 1969;62:610-4.
31. Mehrotra R, Vasstrand EN, Ibrahim SO. Recent advances in understanding carcinogenicity of oral squamous cell carcinoma: From basic molecular biology to latest genomic and proteomic findings. Cancer Gen Proteom 2004; 1:283-94.
32. Weinberg RA. Tumor suppressor genes. Science 1991;254:1138-46,52.
33. Schepman KP, van der Waal I. A proposal for classification and staging system for oral leukoplakia: A preliminary study. Oral Oncol 1995;31B:396-8.
34. Grandis JR, Tweardy D. Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res 1993;53:3579-84.
35. rd World assembly on tobacco counters health, Book of Abstracts: 2004. p. 36.
36. Reddel RR. Alternative lengthening of telomeres, telomerase and cancer. Cancer Lett 2003; 194:155-62.
37. Mao L, Lee JS, Fan YH, Ro JY, Batsakis JG, Lippman S, et al. Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nat Med 1996;6:682-5.
38. Miyoshi Y, Tsukinoki K, Imaizumi T, Yamada Y, Ishizaki T, Watanabe Y, et al. Telomerase activity in oral cancer. Oral Oncol 1999;35:283-9.
39. Califano J, Ahrendt SA, Meininger G, Westra WH, Koch WM, Sidransky D. Detection of telomerase activity in oral rinses from head and neck squamous cell carcinoma patients. Cancer Res 1996;56:5720-2.
40. Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer 2003;3:401-10.
41. Kerbel RS. Tumor angiogenesis: Past, present and the near future. Carcinogenesis 2000;21:505-15.
42. Mehrotra R, Varricchio F, Husain SR, Puri RK. Head and neck cancers, but not benign lesions, express interleukin-4 receptors in situ. Oncol Rep 1998;5:45-8.
43. Mehrotra R. Interleukin 13 is secreted by human head and neck tumours and does not modulate their growth in vitro. Indian J Exp Biol 1998;36;805-7.
44. Shillitoe EJ, May M, Patel V, Lethanakul C, Ensley JF, Strausberg RL, et al. Genome-wide analysis of oral cancer-Early results from the Cancer Genome Anatomy Project. Genome Anatomy Project. Oral Oncol 2000;36:8-16.
45. Garnis C, Campbell J, Zhang L. Rosin MP, Lam WL. OCGR array: An oral cancer genomic regional array for comparative genomic hybridization analysis. Oral Oncol 2004;40:511-9.
46. Leethanakul C, Patel V, Gillespie J, Pallente M, Ensley JF, Koontongkaew S, et al. Distinct pattern of expression of differentiation and growth-related genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture micro dissection and cDNA arrays. Oncogene 2000; 19:3220-4.
47. Belbin TJ, Singh B, Barber I, Socci N, Wenig B, Smith R, et al. Molecular classification of head and neck squamous cell carcinoma using cDNA microarrays. Cancer Res 2002;62:1184-90.
48. Mendez E, Cheng C, Farwell DG, Ricks S, Agoff SN, Futran ND, et al. Transcriptional expression profiles of oral squamous cell carcinomas. Cancer 2002;95:1482-94.
49. Lemaire F, Millon R, Young J, Cromer A, Wasylyk C, Schultz I, et al. Differential expression profiling of head and neck squamous cell carcinoma (HNSCC). Br J Cancer 2003;86:1940-9.
50. Ginos MA, Page GP, Michalowicz BS, Patel KJ, Volker SE, Pambuccian SE, et al. Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck. Cancer Res 2004;64:55-63.
51. Marvin LF, Roberts MA, Fay LB. Matrix-assisted laser desorption/ ionization time-of-flight mass spectrometry in clinical chemistry. Clin Chim Acta 2003;337:11-21.
52. Fend F, Emmert-Buck MR, Chuaqui R, Cole K, Lee J, Liotta LA et al. Immuno-LCM: Laser capture micro dissection of immunostained frozen sections for mRNA analysis. Am J Pathol 1999; 154:61-6.
53. Khuri FR, Nemunaitis J, Ganly I, Arseneau J, Tannock IF, Romel L, et al. A controlled trial of intratumoral ONYX-015, a selectively replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nature Med 2000;6:879-85.
54. Dykxhoorn DM, Novina CD Sharp PA. Killing the messenger: Short RNAs that silence gene expression. Nat Rev Mol Cell Biol 2003;4:457-67.